News

Nuevolution has signed an agreement with Boehringer Ingelheim to screen a range of small molecules for discovering and enhancing drug candidates by using Nuevolution's proprietary Chemetics drug discovery technology. The drugs which will be...

Moberg Derma has given marketing license for its over-the-counter Nalox to Meda as a treatment for discolored and damaged nails caused by nail fungus or nail psoriasis. The new deal covers several major European...

Cellerant Therapeutics has received additional funding of approximately $16.7m from Biomedical Advanced Research and Development Authority to advance CLT-008 development as a treatment for acute radiation syndrome . The additional funding is expected to...

Ono Pharmaceutical has entered into an agreement to develop and commercialize KAI Pharmaceuticals' lead product candidate KAI-4169 in Japan. KAI-4169, an intravenous (IV) formulation used in the treatment of secondary hyperparathyroidism in patients with...

Merck and BGI have teamed up to jointly discover and develop biomarkers and genomic technologies. As per the deal, both the firms will work together for identifying and characterizing biomarkers for drug development, drug...

Frontage Laboratories and Spaulding Clinical Research have entered into an agreement to strengthen their expertise in China. Under the agreement, Frontage will combine its drug formulation and Bioanalytical analysis expertise with Spaulding Clinical's Cardiac...

PharmAthene has accomplished significant progress in the development of SparVax, a second generation recombinant protective antigen anthrax vaccine. PharmAthene's rPA anthrax vaccine program has been funded in whole or in part with Federal funds...